XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Balances (in shares) at Dec. 31, 2018   64,185      
Balances at Dec. 31, 2018 $ 220,335 $ 6 $ 402,934 $ (182,600) $ (5)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of options (in shares)   14      
Issuance of common stock upon exercise of options 25   25    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   132      
Stock-based compensation 2,702   2,702    
Shares withheld for payment of employee's withholding tax liability (216)   (216)    
Net income (loss) (14,301)     (14,301)  
Balances (in shares) at Mar. 31, 2019   64,331      
Balances at Mar. 31, 2019 208,545 $ 6 405,445 (196,901) (5)
Balances (in shares) at Dec. 31, 2018   64,185      
Balances at Dec. 31, 2018 220,335 $ 6 402,934 (182,600) (5)
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (24,575)        
Balances (in shares) at Sep. 30, 2019   80,680      
Balances at Sep. 30, 2019 248,434 $ 8 455,601 (207,175) 0
Balances (in shares) at Mar. 31, 2019   64,331      
Balances at Mar. 31, 2019 208,545 $ 6 405,445 (196,901) (5)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under employee stock purchase plan (in shares)   64      
Issuance of common stock under employee stock purchase plan 158   158    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   426      
Stock-based compensation 2,634   2,634    
Shares withheld for payment of employee's withholding tax liability (293)   (293)    
Net income (loss) (13,605)     (13,605)  
Balances (in shares) at Jun. 30, 2019   64,821      
Balances at Jun. 30, 2019 197,439 $ 6 407,944 (210,506) (5)
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   42      
Issuance of common stock in conjunction with the Convertible Note Exchange (in shares)   15,817      
Issuance of common stock in conjunction with the Convertible Note Exchange 25,307 $ 2 25,305    
Reacquisition of equity component of 2021 Notes and 2024 Notes (4,796)   (4,796)    
Equity component of issued 2024 Notes, net of tax 24,165   24,165    
Stock-based compensation 3,004   3,004    
Shares withheld for payment of employee's withholding tax liability (19)   (19)    
Net income (loss) 3,331     3,331  
Unrealized loss on available-for-sale securities 5       5
Balances (in shares) at Sep. 30, 2019   80,680      
Balances at Sep. 30, 2019 248,434 $ 8 455,601 (207,175) $ 0
Balances (in shares) at Dec. 31, 2019   80,888      
Balances at Dec. 31, 2019 57,958 $ 8 457,751 (399,801)  
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   434      
Reacquisition of equity component of 2021 Notes and 2024 Notes (16,814)   (16,814)    
Stock-based compensation 1,934   1,934    
Shares withheld for payment of employee's withholding tax liability (271)   (271)    
Net income (loss) 41,230     41,230  
Balances (in shares) at Mar. 31, 2020   81,322      
Balances at Mar. 31, 2020 84,037 $ 8 442,600 (358,571)  
Balances (in shares) at Dec. 31, 2019   80,888      
Balances at Dec. 31, 2019 57,958 $ 8 457,751 (399,801)  
Increase (Decrease) in Stockholders' Equity          
Net income (loss) (3,791)        
Balances (in shares) at Sep. 30, 2020   107,174      
Balances at Sep. 30, 2020 75,950 $ 12 479,530 (403,592)  
Balances (in shares) at Mar. 31, 2020   81,322      
Balances at Mar. 31, 2020 84,037 $ 8 442,600 (358,571)  
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock under employee stock purchase plan (in shares)   76      
Issuance of common stock under employee stock purchase plan 49   49    
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   215      
Issuance of common stock in conjunction with the Zyla Merger (in shares)   25,479      
Issuance common stock, warrants, and stock options in conjunction with the Zyla Merger 22,931 $ 3 22,928    
Issuance of warrants and stock options in conjunction with the Zyla Merger 11,626   11,626    
Reacquisition of equity component of 2021 Notes and 2024 Notes (2,718)   (2,718)    
Stock-based compensation 3,593   3,593    
Shares withheld for payment of employee's withholding tax liability (41)   (41)    
Net income (loss) (34,499)     (34,499)  
Balances (in shares) at Jun. 30, 2020   107,092      
Balances at Jun. 30, 2020 84,978 $ 11 478,037 (393,070)  
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)   82      
Issuance of common stock in conjunction with vesting of restricted stock units 1 $ 1      
Stock-based compensation 1,511   1,511    
Shares withheld for payment of employee's withholding tax liability (18)   (18)    
Net income (loss) (10,522)     (10,522)  
Balances (in shares) at Sep. 30, 2020   107,174      
Balances at Sep. 30, 2020 $ 75,950 $ 12 $ 479,530 $ (403,592)